Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inify Laboratories AB Director's Dealing 2026

Jan 27, 2026

6123_dirs_2026-01-27_9c43028d-9db7-4ac5-82e4-94120ad68a43.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

{0}------------------------------------------------

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Monsun AS
2 Reason for the notification
a) Position/status A company closely associated with Magne Jordanger, member of the
board of directors of Inify Laboratories AB (publ)
b) Initial Notification
/ Amendment
Initial
3 Details of the issuer
a) Name Inifiy Laboratories AB (publ)
b) LEI 549300306YYJ3BX3VB98
4 Details of the transaction:
a) Description of the
financial
instrument,
type of
instrument
Identification code
Shares in Inify Laboratories AB (publ), with ISIN SE0017486103
b) Nature of the
transaction
Subscription and allocation of new shares in repair issue
c) Price(s) and
volume(s) Price Volume(s)
NOK 3.5 898,204
d) Aggregated
information
— Aggregated
volume
— Price
Price Volume(s)
NOK 3.5 898,204
e) Date of the
transaction
2026-01-27
f) Place of the
transaction
Outside a trading venue

{1}------------------------------------------------

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Olof Sandén
2 Reason for the notification
a) Position/status Chair of the board of directors of Inify Laboratories AB (publ)
b) Initial Notification
/ Amendment
Initial
3 Details of the issuer
a) Name Inifiy Laboratories AB (publ)
b) LEI 549300306YYJ3BX3VB98
4 Details of the transaction:
a) Description of the
financial
instrument,
type of
instrument
Identification code
Shares in Inify Laboratories AB (publ), with ISIN SE0017486103
b) Nature of the
transaction
Subscription and allocation of new shares in repair issue
c) Price(s) and
volume(s) Price Volume(s)
NOK 3.5 43,139
d) Aggregated
information
— Aggregated
volume
— Price
Price Volume(s)
NOK 3.5 43,139
e) Date of the
transaction
2026-01-27
f) Place of the
transaction
Outside a trading venue

{2}------------------------------------------------

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Martin Ingvar
2 Reason for the notification
a) Position/status Member of the board of directors of Inify Laboratories AB (publ)
b) Initial Notification
/ Amendment
Initial
3 Details of the issuer
a) Name Inifiy Laboratories AB (publ)
b) LEI 549300306YYJ3BX3VB98
4 Details of the transaction:
a) Description of the
financial
instrument,
type of
instrument
Identification code
Shares in Inify Laboratories AB (publ), with ISIN SE0017486103
b) Nature of the
transaction
Subscription and allocation of new shares in repair issue
c) Price(s) and
volume(s) Price Volume(s)
NOK 3.5 67,132
d) Aggregated
information
— Aggregated
volume
— Price
Price Volume(s)
NOK 3.5 67,132
e) Date of the
transaction
2026-01-27
f) Place of the
transaction
Outside a trading venue

{3}------------------------------------------------

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Fredrik Palm
2 Reason for the notification
a) Position/status CEO of Inify Laboratories AB (publ)
b) Initial Notification
/ Amendment
Initial
3 Details of the issuer
a) Name Inifiy Laboratories AB (publ)
b) LEI 549300306YYJ3BX3VB98
4 Details of the transaction:
a) Description of the
financial
instrument,
type of
instrument
Identification code
Shares in Inify Laboratories AB (publ), with ISIN SE0017486103
b) Nature of the
transaction
Subscription and allocation of new shares in repair issue
c) Price(s) and
volume(s) Price Volume(s)
NOK 3.5 36,564
d) Aggregated
information
— Aggregated
volume
— Price
Price Volume(s)
NOK 3.5 36,564
e) Date of the
transaction
2026-01-27
f) Place of the
transaction
Outside a trading venue

{4}------------------------------------------------

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Ann-Charlotte Linderoth
2 Reason for the notification
a) Position/status CFO of Inify Laboratories AB (publ)
b) Initial Notification
/ Amendment
Initial
3 Details of the issuer
a) Name Inifiy Laboratories AB (publ)
b) LEI 549300306YYJ3BX3VB98
4 Details of the transaction:
a) Description of the
financial
instrument,
type of
instrument
Identification code
Shares in Inify Laboratories AB (publ), with ISIN SE0017486103
b) Nature of the
transaction
Subscription and allocation of new shares in repair issue
c)
Price(s) and
volume(s) Price Volume(s)
NOK 3.5 26,433
d) Aggregated
information
— Aggregated
volume
— Price
Price Volume(s)
NOK 3.5 26,433
e) Date of the
transaction
2026-01-27
f) Place of the
transaction
Outside a trading venue